RTW Investments, L.P., 10% Owner at Tarsus Pharmaceuticals, Inc. (TARS), sold 450,000 shares at $29.98 ($13.5M) on 2021-05-07, disclosed to the SEC on 2021-05-07.
Open-market sale of $13.5M TARS by 10% Owner. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| Filing → |
| OBIO | BUY | 2025-04-29 | $253K | — | Filing → |
| DMTK | SELL | 2022-11-08 | $177K | — | Filing → |
| RCKT | BUY | 2022-10-11 | $20.0M | — | Filing → |